Company Data
Cingulate Inc.
Ticker
CING
Current Price
$5.08 -1.74%
Market Cap
$73.9M
Price Target
Refer to Report
Volume
42.2K
52wk Range
$3.16 - $11.89
Overview
Cingulate Inc is a clinical stage biopharmaceutical company utilizing its proprietary precision timed release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes.